Раздел 3.31. American College of Surgeons Cancer Research Program. Operative Standards for Cancer Surgery: Volume 3; 2022.2. Wittekind C., Compton C.C., Greene F.L., Sobin L.H. TNM residual tumor classification revisited. Cancer 2002;94(9):2511–6.3. Tunn P.U., Kettelhack C., Durr H.R. Standardized approach to the treatment of adult soft tissue sarcoma of the extremities. Recent ResultsCancer Res 2009;179:211–28.4. Fletcher C.D.M., Unni K.K., Mertens F. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. World Health Organization Classification of Tumours. Vol. 5. Р. 70.5. NCCN Guidelines Version 1.2024 Soft Tissue Sarcoma. April 26, 2024.6. Casali P.G., Abecassis N. et al. The ESMO/European Sarcoma Nrtwork Working Group Ann of Oncol (Supplement 4); iv51-iv67, 20237. Практические рекомендации по лечению злокачественных опухолей Российского общества клинической онкологии (RUSSCO). Саркомы мягких тканей. 2023; том13: 356-374. 8. Traub F., Griffin A.M. et al. Influence of Unplanned Excisions on the Outcomes of Patients With Stage III Extremity Soft-Tissue Sarcoma. Cancer, Vol. 124, 2018, P. 3787-3949.9. Kapoor T., Banuelos J. et al. Analysis of clinical outcomes of upper and lower extremity reconstructions in patients with soft-tissue sarcoma. J Surg Oncol. 2018 Sep; 118(4):614-620.10. Fourman M.S., Ramsey D.C., Newman E.T., et al. Assessing the safety and utility of wound VAC temporization of the sarcoma or benign aggressive tumor bed until final margins are achieved. Ann Surg Oncol 2022;29:2290-2298.11. Fourman M.S., Ramsey C., Kleiner J., et al. Temporizing wound VAC dressing until final negative margins are achieved reduces myxofibrosarcoma local recurrence. Ann Surg Oncol 2021; 28:9171-9176.12. Berner J.E., Crowley T.P., Teelucksingh S., et al. The importance of clear margins in myxofibrosarcoma: Improving local control by means of staged resection and reconstruction. Eur J Surg Oncol 2021;47:2627-2632.13. Zagars G.K., Ballo M.T., Pisters P.W.T., et al. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer 2003;97:2544-2553.14. O'Donnell P.W., Griffin A.M., Eward W.C., et al. The effect of the setting of a positive surgical margin in soft tissue sarcoma. Cancer 2014;120:2866-2875.15. Gundle K.R., Kafchinski L., Gupta S., et al. Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection. J Clin Oncol 2018;36:704-709.16. Kainhofer V.., Smolle MA., Szkandera J., et al. The width of resection margins influences local recurrence in soft tissue sarcoma patients. Eur J Surg Oncol 2016;42:899-906.17. Ecker B.L., Peters M.G., McMillan M.T., et al. Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma. Ann Surg Oncol 2017;24:425-433.18. Ethun C., Lopez-Aguiar A. et al. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database. Annals of Surgical Oncology, 2019, Vol. 26, pp 4723–4729.19. Pisters P.W., Leung D.H, Woodruff J., et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-1689. 20. Fleming J.B., Berman R.S., Cheng S.C., et al. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol 1999;17:2772-2780.21. Gerrand C.H., Wunder J.S., Kandel R.A., et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J Bone Joint Surg Br 2001;83:1149-1155.22. McKee M.D., Liu D..F, Brooks J.J., et al. The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 2004;85:68- 76.23. Biau D.J., Ferguson P.C., Chung P., et al. Local recurrence of localized soft tissue sarcoma: a new look at old predictors. Cancer 2012;118:5867-5877.24. Alamanda V.K., Crosby S.N., Archer K.R., et al. Predictors and clinical significance of local recurrence in extremity soft tissue sarcoma. Acta Oncol 2013;52:793-802.25. Clark M.A., Thomas J.M. Amputation for soft-tissue sarcoma. Lancet Oncol 2003;4:335-342.26. Rosenberg S.A., Tepper J., Glatstein E., et al. The treatment of soft- tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982;196:305-315.27. Baldini E.H., Goldberg J., Jenner C., et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17:3252-3259.28. Lin P.P., Guzel V.B.., Pisters PW., et al. Surgical management of soft tissue sarcomas of the hand and foot. Cancer 2002;95:852-861.29. Williard W.C., Hajdu S.I., Casper E.S., Brennan M.F. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann Surg 1992;215:269-275.30. Stojadinovic A., Jaques D.P., Leung D.H., et al. Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann Surg Oncol 2001;8:509-518.31. Ghert M.A., Abudu A., Driver N., et al. The indications for and the prognostic significance of amputation as the primary surgical procedure for localized soft tissue sarcoma of the extremity. Ann Surg Oncol 2005;12:10-17.32. Alamanda V.K., Crosby S.N., Archer K.R., et al. Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol 2012;38:1178-1183.33. Geer R.J., Woodruff J., Casper E.S., Brennan M.F. Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg 1992;127:1285-1289.34. Karakousis C.P., Emrich L.J., Rao U., Khalil M. Limb salvage in soft tissue sarcomas with selective combination of modalities. Eur J Surg Oncol 1991;17:71-80.35. Cahlon O., Spierer M., Brennan M.F., et al. Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy. Cancer 2008;112:2774-2779.36. Kang J., Botros M., Goldberg S., et al. The use of radiation therapy in the management of selected patients with atypical lipomas. Sarcoma 2013;2013:485483-485483. 37. Pisters P.W., Pollock R.E., Lewis V.O., et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 2007;246:675-681; discussion 681-682.38. Al-Refaie W.B., Habermann E.B., Jensen E.H., et al. Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremity. Br J Surg 2010;97:707-713.39. Greene F.L., Page D.L., Fleming I.D., et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.40. Kane J.M., Finley J.W., Driscoll D., et al. The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases. Sarcoma 2002;6:69-73. 41. Ferguson P.C., Deheshi B.M., Chung P., et al. Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection. Cancer 2011;117:372-379. 42. Anaya D.A., Lev D.C., Pollock R.E. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol 2008;98:607-610. 43. Bevilacqua R.G., Rogatko A., Hajdu S.I., Brennan M.F. Prognostic factors in primary retroperitoneal soft-tissue sarcomas. Arch Surg 1991;126:328-334.44. Heslin M.J., Lewis J.J., Nadler E., et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997;15:2832-2839. 45. Lewis J.J., Leung D., Woodruff J.M., Brennan M.F. Retroperitoneal soft- tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998;228:355-365.46. Bremjit P.J., Jones R.L., Chai X., et al. A contemporary large single- institution evaluation of resected retroperitoneal sarcoma. Ann Surg Oncol 2014;21:2150-2158.47. Bonvalot S., Rivoire M., Castaing M., et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009;27:31-37.48. Gronchi A., Lo Vullo S., Fiore M., et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009;27:24-30.49. Ballo M.T., Zagars G.K., Pollock R.E., et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 2007;67:158-163.50. Gronchi A., Casali P.G., Fiore M., et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004;100:2448-2455.51. Stoeckle E., Coindre J.M., Bonvalot S., et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001;92:359-368.52. Raut C.P., Pisters P.W.T. Retroperitoneal sarcomas: combined- modality treatment approaches. J Surg Oncol 2006;94:81-87.53. Zlotecki R.A., Katz T.S., Morris C.G., et al. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 2005;28:310-316.54. Mendenhall W.M., Zlotecki R.A., Hochwald S.N., et al. Retroperitoneal soft tissue sarcoma. Cancer 2005;104:669-675. 55. Windham T.C., Pisters P.W.T. Retroperitoneal sarcomas. Cancer Control 2005;12:36-43.56. Singer S., Corson J.M., Demetri G.D., et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995;221:185-195.57. Lev D., Kotilingam D., Wei C., et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007;25:1785-1791. 58. Pritchard D.J., Nascimento A.G., Petersen I.A.. Local control of extra- abdominal desmoid tumors. J Bone Joint Surg Am 1996;78:848-854. 59. Ballo M.T., Zagars G.K., Pollack A., et al. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158-167. 60. Stojadinovic A., Hoos A., Karpoff H.M., et al. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg 2001;136:70-79.61. Ma D., Li S., Fu R., et al. Long-term outcomes of 47 patients with aggressive fibromatosis of the chest treated with surgery. Eur J Surg Oncol 2016;42:1693-1698.62. Gronchi A., Casali P.G., Mariani L., et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol 2003;21:1390-1397.63. Peng P.D., Hyder O., Mavros M.N., et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol 2012;19:4036-4042.64. Melis M., Zager J.S., Sondak V.K. Multimodality management of desmoid tumors: how important is a negative surgical margin? J Surg Oncol 2008;98:594-602.65. Huang K., Fu H., Shi Y.Q., et al. Prognostic factors for extra- abdominal and abdominal wall desmoids: a 20-year experience at a single institution. J Surg Oncol 2009;100:563-569.66. Stoeckle E., Coindre J.M., Longy M., et al. A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases. Eur J Surg Oncol 2009;35:129-134. 67. Mullen J.T., Delaney T.F., Kobayashi W.K., et al. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 2012;19:4028-4035. 68. Janssen M.L., van Broekhoven D.L., Cates J.M., et al. Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis. Br J Surg 2017;104:347-357.69. Gluck I., Griffith K.A., Biermann J.S., et al. Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys 2011;80:787-792.70. Crago A.M., Denton B., Salas S., et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg 2013;258:347-353.71. Salas S., Dufresne A., Bui B., et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation. J Clin Oncol 2011;29:3553-3558. 72. Cates J.M., Stricker T.P. Surgical resection margins in desmoid-type fibromatosis: a critical reassessment. Am J Surg Pathol 2014;38:1707-1714. 73. Crago A.M., Denton B., Salas S., et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg 2013;258:347-353.74. Goy B.W., Lee S.P., Eilber F., et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 1997;39:659-665. 75. Jelinek J.A., Stelzer K.J., Conrad E., et al. The efficacy of radiotherapy as postoperative treatment for desmoid tumors. Int J Radiat Oncol Biol Phys 2001;50:121-125.76. Fontanesi J., Mott M.P., Kraut M.J., et al. The role of postoperative irradiation in the treatment of locally recurrent incompletely resected extra-abdominal desmoid tumors. Sarcoma 2004;8:83-86.77. Baumert B.G., Spahr M.O., Von Hochstetter A., et al. The impact of radiotherapy in the treatment of desmoid tumours. An international survey of 110 patients. A study of the Rare Cancer Network. Radiat Oncol 2007;2:12-12. 78. Guadagnolo B.A., Zagars G.K., Ballo M.T. Long-term outcomes for desmoid tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys 2008;71:441-447. 79. Santti K., Beule A., Tuomikoski L., et al. Radiotherapy in desmoid tumors : Treatment response, local control, and analysis of local failures. Strahlenther Onkol 2017.80. Bonvalot S., Eldweny H., Haddad V., et al. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 2008;34:462-468. 81. Fiore M., Rimareix F., Mariani L., et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009;16:2587-2593.